Are you a medical professional with a strong interest in radiation medicine? Can you see a future where all cancers can be targeted by one treatment?
Help us in our global effort to better control and cure cancer by becoming a TROG Cancer Research Member.
TROG (Trans-Tasman Radiation Oncology Group) Cancer Research is the peak Australasian body committed to improving the way radiation medicine is delivered to cancer patients. Our vision is to improve outcomes for people affected by cancer through ongoing research in radiation medicine and treatment options.
TROG Cancer Research is one of the highest recruiting collaborative trials group in Australia. By becoming a member, you’ll help advance clinical research into a treatment that benefits many cancers including breast, skin, lung, prostate and bladder, gynaecological, and head and neck.
Become part of our network of more than 1,400 professionals who are committed to innovation and continuous improvement.
It is also open to anyone qualified or training in a radiation therapy-related discipline and offers a range of benefits, including:
This membership is extended to anyone fully qualified in their discipline.
If you are a radiation oncologist, medical oncologist, radiation therapist, interventional oncologist, medical physicist, statistician, data manager, nurse, or surgeon, we welcome your input.
For just $180+gst per year, full TROG Cancer Research Members can:
All TROG Cancer Research members can access the member section of the website which includes:
Access to TROG e-learning platform encompassing GCP training and more.
Copies of trial documents including protocols.
Minutes and presentations from meetings.
TROG Policy and Procedures Manuals.
Access to trial and RTQA resources.
Applications for membership require a personal recommendation by two full members (a Proposer and a Seconder). As part of the application process, you will be asked to select two full members who will be contacted by the TROG Central Operations Office to confirm their support for your application.
Once approval has been obtained by your nominated two full members, and the subscription has been paid (if applying for full membership) your membership will be activated and you will receive your login details.
TROG Cancer Research is a company limited by guarantee under the Corporations Act. The liability of members is limited to payment of a nominal guarantee of $10 if the company is wound up. If required, this contribution would support payment of the debts and liabilities of the company, including the costs of the winding up.
By subscribing as a full member of TROG Cancer Research you undertake to provide this guarantee in the amount of $10, if required. This undertaking continues for one year after a member ceases to be a member of the company.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292